Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease

We evaluated the pharmacokinetics and efficacy of oral mycophenolate mofetil (MMF) for treatment of refractory graft-versus-host disease (GVHD). In a prospective study of acute GVHD, 9 of 19 patients (47%) had a response and 10 (53%) had no improvement. Survival at 6 and 12 months after the start of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Furlong, Terry, Martin, Paul, Flowers, Mary E.D., Carnevale-Schianca, Fabrizio, Yatscoff, Randy, Chauncey, Thomas, Appelbaum, Frederick R., Deeg, H. Joachim, Doney, Kris, Witherspoon, Robert, Storer, Barry, Sullivan, Keith M., Storb, Rainer, Nash, Richard A.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2791193/
https://ncbi.nlm.nih.gov/pubmed/19377515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2009.76
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars